Sayaka Sugihara

Last Updated :2024/07/03

Affiliations, Positions
Research Institute for Radiation Biology and Medicine, Assistant Professor
Other Contact Details
1-2-3, Kasumi, Minami-ku, Hiroshima Japan, Japan
TEL : (+81)82-257-5877 FAX : (+81)

Basic Information

Major Professional Backgrounds

  • 1999/05/16, 2000/09/30, Hiroshima University, Medical Hospital, Clinical Resident
  • 2000/10/01, 2001/03/31, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital
  • 2001/04/01, 2001/05/05, Hiroshima University, Medical Hospital, Clinical Resident
  • 2001/05/06, 2002/03/30, Hiroshima University, Medical Hospital, Clinical Fellow
  • 2004/04/01, 2007/03/31, Hiroshima University Hospital, Clinical Fellow
  • 2007/04/01, 2011/03/31, Hiroshima University Hospital, Clinical Fellow
  • 2011/04/01, 2013/10/31, Foundation for AIDS Prevention, Research Resident
  • 2013/11/01, Hiroshima University, Research Institute for Radiation Biology and Medicine, Assistant Professor

Educational Backgrounds

  • Hiroshima University, Japan, 2004/04, 2010/11
  • Ehime University, Japan, 1993/04, 1999/03

Academic Degrees

  • Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Hematology
  • Environmental science;Environmental analyses and evaluation;Risk sciences of radiation and chemicals

Research Keywords

  • Atomic bomb victims and survivors. The effect of atomic radiation.

Affiliated Academic Societies

Educational Activity

Course in Charge

  1. 2024, Undergraduate Education, Year, Clinical diagnosis and treatment II
  2. 2024, Undergraduate Education, Intensive, Practice of Medicine I
  3. 2024, Undergraduate Education, Intensive, Practice of Medicine II

Research Activities

Academic Papers

  1. Progressive Multifocal Leukoencephalopathy in Relapsed Ph plus Acute Lymphoblastic Leukemia after Cord Blood Transplantation and Blinatumomab Treatment: A Case Report and Literature Review, ACTA HAEMATOLOGICA, 145(6), 655-660, 2022
  2. Three patients who developed torsades de pointes during therapy with anthracycline derivative drug, 20(5), 632-636, 20041225
  3. Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia, Rinsho Ketsueki, 49(1), 46-50, 20080130
  4. Cerebral Sinus Thrombosis and Heparin-induced Thrombocytopenia in a Patient with Paroxysmal Nocturnal Hemoglobinuria, Japanese Journal of Medicine, 49(10), 941-943, 2010
  5. Is Eradication Therapy Useful as the First Line of Treatment in Helicobacter pylori-Positive Idiopathic Thrombocytopenic Purpura? Analysis of 207 Eradicated Chronic ITP Cases in Japan, Int J Hematol, 81(2), 162-168, 20050215
  6. ★, Roles of Src-like adaptor protein 2 (SLAP-2) in GPVI-mediated platelet activation SLAP-2 and GPVI signaling., Thromb Res., 126(4), 276-285, 201010
  7. A Case of Recurrent Ischemic Stroke Involving Subacute, Progressive Intracranial Cerebral Arterial Sclerosis Prior to Diagnosis with JAK2-mutated Polycythemia Vera, JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 24(12), E4-E6, 201512
  8. Roles of Src-like adaptor protein 2 (SLAP-2) in GPVI-mediated platelet activation SLAP-2 and GPVI signaling, THROMBOSIS RESEARCH, 126(4), E276-E285, 2010
  9. Splenectomy followed by administration of rituximab is useful to treat a patient with hairy cell leukemia-variant, ANNALS OF HEMATOLOGY, 92(5), 711-713, 2013
  10. Re-assessment of the medical records of atomic-bomb victims. -a model of the atomic-bomb investigations conducted by Kyoto Imperial University., The Journal of The Hiroshima Medical Association, 69(4), 366-368, 20160428
  11. Problems in Possibility of epidemiological studies and the document organization: case study of the investigations conducted by Kyoto imperial University., The Journal of the Hiroshima Medical Association, 69(4), 362-365, 20160428
  12. Molecular genetic analysis of inherited protein C deficiency caused by the novel large deletion across two exons of PROC, Thrombosis Research, 188(4), 115-118, 20200401

Invited Lecture, Oral Presentation, Poster Presentation

  1. Crowdfunding for 'Preserving A-Bomb Victims' Records for Future Generations: Specimen Database Project', Sayaka Sugihara, Akiko Kubota, Shinji Yoshinaga, 2023/02/20, Without Invitation, English
  2. Dynamics of immune repertoire after SARS-CoV-2 vaccination in recipients of allogeneic HCT., Tetsumi Yoshida, Yuji Hirata, Kazutaka Kitaura, Ren Chishaki, Keita Fujino, Taro Edahiro, Tatsuji Mino, Kayo Toishigawa, Sayaka Sugihara, Yukiko Nakamura, Shin-Ichi Yamazaki, Michiya Yokozaki, Yukio Nakamura, Masatoshi Nishizawa, Noriyasu Fukushima, Ryuji Suzuki, Tatsuo Ichinohe, 2022/10/15, Without Invitation, Japanese
  3. Development of the databases for the glass slide specimens of A-bomb victims through a crowdfunding campaign, 2022/09/16, With Invitation, Japanese
  4. Deterioration of the preparation specimens from the atomic bomb victims, Sayaka Sugihara, Akiko Kubota, and Shinji Yoshinaga, 2021/02/08, Without Invitation, English
  5. Is it necessary to perform the central nervous system prophylaxis in primary cardiac lymphoma?, Taro Edahiro, Noriyasu Fukushima, Ren Chishaki, Tetsumi Yoshida, Tatsuji Mino, Sayaka Sugihara, Masatoshi Nishizawa, Tatsuo Ichinohe., 2021/09/23, Without Invitation, Japanese
  6. Real-world clinical utility of next-generation-sequencer-based gene panel test for myeloid neoplsms, Masatoshi Nishizawa, Ren Chishaki, Taro Edahirto, Tatsuji Mino, Tetsumi Yoshida, Sayaka Sugihara, Noriysasu Fukushima, Tatsuo Ichinohe., 2021/09/24, Without Invitation, Japanese